Compound ID | 429
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Compared to cefpirome, ceftazadime, cefotaxime, ceftriaxone and cephaloloridine, LB 10522 demonstrated greatest stability against hydrolysis by β-lactamases. However, it was susceptible to a level of hydrolysis by TEM-5 and TEM-9. It was found to be active against a number of bacterial strains. However, it was also found to be more prone to induce resistance in E. coli and P. aeruginosa than cefpirome |
| Description: | Kim M, Song H, et al. LB10522, a new catechol substituted Cephalosporin: II β-lactamase stabilities and biological activities. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995 |
| Institute where first reported: | LG Chem Investment, South Korea |
| Year first mentioned: | 1995 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/10462306 |
| Citation: | https://journals.asm.org/doi/epdf/10.1128/aac.40.8.1825 |